Discharge ALERT: Quality Improvement Initiative

NACompletedINTERVENTIONAL
Enrollment

2,515

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

May 31, 2011

Conditions
Pulmonary EmbolismDeep Vein ThrombosisProphylaxisVenous ThromboembolismPrevention
Interventions
BEHAVIORAL

Alert

The responsible physician will be notified that: 1) his or her patient is at high risk for VTE and 2) VTE prophylaxis should be considered in the Discharge orders

Trial Locations (22)

11030

North Shore University Hospital, Manhasset

12208

Albany Medical Center, Albany

15301

Washington Hospital, Washington

15701

Indiana Regional Medical Center, Indiana

19107

Thomas Jefferson Hospital, Philadelphia

21237

Medstar Research Frankin Square Hospital, Baltimore

21740

Washington County Hospital, Hagerstown

27705

Duke University Medical Center, Durham

48197

St. Joseph Mercy Hospital, Ypsilanti

63141

St. John's Mercy Medical Center, St Louis

65212

University of Missouri- Columbia, Columbia

75231

Presbyterian Hospital Texas Health, Dallas

80262

Denver VA Medical Center, Denver

84132

University of Utah Hospital Medical Center, Salt Lake City

84143

Intermountain Medical Center, Salt Lake City

87102

Lovelace Medical Center, Albuquerque

90822

Long Beach VA Healthcare System, Long Beach

92868

UC Irvine, Orange

95817

UC Davis, Sacramento

06360

William Backus Hospital, Norwich

02115

Brigham and Women's Hospital, Boston

01970

North Shore Medical Center, Salem

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT00853463 - Discharge ALERT: Quality Improvement Initiative | Biotech Hunter | Biotech Hunter